Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.

Clinica chimica acta; international journal of clinical chemistry - 1 Jul 2020

Chang Ya-Sian, Hsiao Li-Yun, Lin Chien-Yu, Shih Mu-Chin, Hsieh Ming-Chia, Chang Jan-Gowth

Abstract excerpt

AIMS: Patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency or thalassemia have a shorter red blood cell lifespan; therefore, HbA1c is underestimated in these patients. To address these issues, we sought an early indicator for G6PD deficiency or thalassemia in DM patients. METHODS: A total of 4908 patients with DM and 1848 subjects without DM were included in this study. Fasting glucose (FG) levels,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Blood Glucose

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Diabetes Mellitus, Type 2

Share to Fasting

Share to Glucosephosphate Dehydrogenase Deficiency

Share to Glycated Hemoglobin

Share to Thalassemia

Share to Young Adult

Source

Identifiers

PMID: 32156605
DOI: 10.1016/j.cca.2020.03.010

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Fasting glucose-to-HbA1c ratio is a good indicator of G6PD deficiency, but not thalassemia, in patients with type 2 diabetes mellitus.PMID 32156605Read ↗

Glucose-6-Phosphate Dehydrogenase Deficiency.Semantic proximity Read ↗

Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.Semantic proximity Read ↗

Hematological parameters and red blood cell morphological abnormality of Glucose-6-Phosphate dehydrogenase deficiency co-inherited with thalassemiaSemantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficiency: a historical perspectiveSemantic proximity Read ↗

Prediction the Occurrence of Thalassemia With Hematological Phenotype by Diagnosis of Abnormal HbA1c.Semantic proximity Read ↗

Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.Semantic proximity Read ↗

Glucose-6-phosphate dehydrogenase deficiencySemantic proximity Read ↗

Evaluating the relationship between Clinical G6PD enzyme activity and gene variants.Semantic proximity Read ↗

Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research ProgramSemantic proximity Read ↗

Newborn screening of glucose-6-phosphate dehydrogenase deficiency in Guangxi, China: determination of optimal cutoff value to identify heterozygous female neonates.Semantic proximity Read ↗

Abnormal glucose tolerance in Egyptian beta-thalassemic patients: possible association with genotyping.Semantic proximity Read ↗

Hematological and molecular analysis of patients with G6PD deficiency revealed coexistent hereditary spherocytosis and alpha thalassemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.